Acquisition momentum Exane is now a BNP Paribas subsidiary since 2021, indicating strong integration with a large corporate banking ecosystem. This creates cross-sell opportunities into BNP Paribas client bases and leveraged platform capabilities for expanded product suites.

Midcap focus expansion Recent hires and UK midcap research leadership signal an active push into midmarket equities coverage. This presents a chance to offer tailored research, execution, and liquidity services to mid-sized companies and their investor bases.

European equities strengths Exane’s core Cash Equities and Research excellence across European equities positions them to partner with firms seeking sophisticated equity research, trading, and smart execution solutions in a competitive European market.

Structured solutions Exane Solutions’ breadth in derivatives research, structured products, indices, and smart execution offers potential for clients needing hedging, bespoke product design, and efficient execution in complex markets.

Strategic partnerships Past partnerships and liquidity arrangements with Renault and others indicate openness to alliance models. There is opportunity to propose collaborative liquidity programs, research sponsorships, or joint distribution deals with corporate clients.